Fatores de risco Página 2

Iniciar Sessão

NEJM - Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

The New England Journal of MedicineCoronavirus disease 2019 (Covid-19) may disproportionately affect people with cardiovascular disease. Concern has been aroused regarding a potential harmful effect of angiotensin-converting–enzyme (ACE)...

JAMA - Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death

JAMA NetworkAmong patients with hypertension, do those taking angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) have greater illness severity or increased risk of mortality during hospitalization for...

THE LANCET - Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

The most distinctive comorbidities of 32 non-survivors from a group of 52 intensive care unit patients with novel coronavirus disease 2019 (COVID-19) in the study by Xiaobo Yang and colleagues were cerebrovascular diseases (22%) and diabetes...

ECDC - Information on COVID-19 for specific groups: the elderly, patients with chronic diseases, people with immunocompromising condition and pregnant women

European Centre for Disease Prevention and ControlThe COVID-19 pandemic is evolving fast. Community transmission is currently ongoing throughout several countries in Europe and is expected to expand quickly in other countries in the coming days....

The Lancet - Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

The LancetSince December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients...

1 2

Categorias

Arquivo de Notícias